Formulary Monographs [TIZANIDINE, 122020]
|
|
TIZANIDINE
|
|
|
|
|
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
Spasticity associated with multiple sclerosis and cerebrovascular or spinal cord disorders.
|
|
|
Drowsiness, muscle weakness, dry mouth, fatigue, insomnia, G.I. disturbances, dizziness.
|
|
|
Adult: 2-4mg three times daily . Maximum dose is 36mg daily. Safety has not been determined in children.See BDS supply protocols pg. 11.
|
|
|
|
|
|
Avoid Tizanidine during pregnancy.
|
|
|
Avoid breastfeeding during Tizanidine therapy.
|
|
|
|